Oncology IS the future of Merck

Discussion in 'Merck' started by Anonymous, Aug 28, 2014 at 9:12 PM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    We will sell more in Alzheimer's in 2021 than we will in Oncology.
     

  2. Anonymous

    Anonymous Guest

    Oncology may be the future of Merck, but is Merck the place to be for Oncology?
     
  3. Anonymous

    Anonymous Guest

    Merck is a truly great place to develop a worth while career. However, you must apply your skills and work hard. Don't accept the BS propagated by the lowlife that populate these threads. Enter the competition and leave a millionaire.
     
  4. Anonymous

    Anonymous Guest

    Merck may not have a bright future. (A lot of things need to to go right).
     
  5. Anonymous

    Anonymous Guest

    What needs to occur is now into the rollout state, massive reductions in all departments all transfer of all sales to contract.
     
  6. Anonymous

    Anonymous Guest

    Right on .. Even oncology ..right on.
     
  7. Anonymous

    Anonymous Guest

    That's why oncology is expanding, right.

    A company with a market cap of $145 billion which grew 26% last year is disappearing. Of course, some of that growth is on the back of reductions in expenses but 26% is solid growth and a multi-billion dollar product in oncology is a sweet addition to the top line.

    All the gloom and doom is for the completely uninformed and unskilled.
     
  8. Anonymous

    Anonymous Guest

    Your likely to experience doom and gloom soon. Mass layoffs on horizon and big increases in insurance costs. Oncology will not survive due to it's very poor management and I'll trained sales personnel.
     
  9. Anonymous

    Anonymous Guest

    Merck just sold a promising oncology drug to Pfizer for two billion! Sounds like a shafting to our group.
     
  10. Anonymous

    Anonymous Guest

    It's the German Merck you doomkoff.
     
  11. Anonymous

    Anonymous Guest

    Before you open with enane comments, you should actually read the press release. It is US Merck! No wonder the oncology group is sooooo inept
     
  12. Anonymous

    Anonymous Guest

    I thought Merck KkgA was The German Merck. Read the article on Fierce Biotech. But it won't matter, Bristol's new oncology drug knocked the ball out of the park. You can read that on Fierce Biotech too!